American Trypanosomiasis (Chagas Disease)

Tropical Infectious Diseases

Volumn , Issue , 2011, Pages 689-695

  Kirchhoff, Louis V ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885171035     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-3935-5.00099-9     Document Type: Chapter

References (177)

1. Levine ND, Corliss JO, Cox FEG, et al. A newly revised classification of the protozoa. J Protozool 1980, 27:37.
2. Guhl F, Vallejo GA Trypanosoma (Herpetosoma) rangeli Tejera, 1920: an updated review. Mem Inst Oswaldo Cruz 2003, 98(4):435.
3. Chagas C Nova tripanozomiase humana. Estudos sobre a morfologia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., agente etiológico de nova entidade mórbida do homem. Mem Inst Oswaldo Cruz 1909, 1:159.
4. Schmunis GA, Cruz JR Safety of the blood supply in Latin America. Clin Microbiol Rev 2005, 18(1):12.
5. Kirchhoff LV, Paredes P, Lomeli-Guerrero A, et al. Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States. Transfusion 2006, 46(2):298.
6. Bern C, Montgomery SP, Katz L, et al. Chagas disease and the US blood supply. Curr Opin Infect Dis 2008, 21(5):476.
7. Schijman AG, Altcheh J, Burgos JM, et al. Aetiological treatment of congenital Chagas disease diagnosed and monitored by the polymerase chain reaction. J Antimicrob Chemother 2003, 52(3):441.
8. Gurtler RE, Segura EL, Cohen JE Congenital transmission of Trypanosoma cruzi infection in Argentina. Emerging Infect Dis 2003, 9(1):29.
9. Diez CN, Manattini S, Zanuttini JC, et al. The value of molecular studies for the diagnosis of congenital Chagas disease in northeastern Argentina. Am J Trop Med Hyg 2008, 78(4):624.
10. Burgos JM, Altcheh J, Petrucelli N, et al. Molecular diagnosis and treatment monitoring of congenital transmission of Trypanosoma cruzi to twins of a triplet delivery. Diagn Microbiol Infect Dis 2009, 65(1):58.
11. Herwaldt BL Protozoa and helminths. Biological Safety: Principles and Practice 2006, 115. American Society for Microbiology, Washington, DC. 4th ed. D.O. Fleming, D.L. Hunt (Eds.).
12. Kinoshita-Yanaga AT, Toledo MJ, Araujo SM, et al. Accidental infection by Trypanosoma cruzi follow-up by the polymerase chain reaction: case report. Rev Inst Med Trop Sao Paulo 2009, 51(5):295.
13. Lent H, Wygodzinsky P Revision of the Triatominae (Hemiptera, Reduviidae), and their significance as vectors of Chagas disease. Bull Am Museum Natural History 1979, 163:123.
14. Starr MD, Rojas JC, Zeledon R, et al. Chagas disease: risk factors for house infestation by Triatoma dimidiata, the major vector of Trypanosoma cruzi in Costa Rica. Am J Epidemiol 1991, 133:740.
15. Enger KS, Ordonez R, Wilson ML, et al. Evaluation of risk factors for rural infestation by Triatoma pallidipennis (Hemiptera: Triatominae), a Mexican vector of Chagas disease. J Med Entomol 2004, 41(4):760.
16. Goble FC South American trypanosomes. Immunity to Parasitic Diseases in Animals 1970, 597. Appleton-Century-Crofts, New York. G.J. Jackson, R. Herman, I. Singer (Eds.).
17. Bradley KK, Bergman DK, Woods JP, et al. Prevalence of American trypanosomiasis (Chagas disease) among dogs in Oklahoma. J Am Vet Med Assoc 2000, 217(12):1853.
18. Villegas-Garcia JC, Santillan-Alarcon S American trypanosomiasis in central Mexico: Trypanosoma cruzi infection in triatomine bugs and mammals from the municipality of Jiutepec in the state of Morelos. Ann Trop Med Parasitol 2004, 98(5):529.
19. Kjos SA, Snowden KF, Craig TM, et al. Distribution and characterization of canine Chagas disease in Texas. Vet Parasitol 2008, 152(3-4):249.
20. Roque AL, Xavier SC, da Rocha MG, et al. Trypanosoma cruzi transmission cycle among wild and domestic mammals in three areas of orally transmitted Chagas disease outbreaks. Am J Trop Med Hyg 2008, 79(5):742.
21. Klotz SA, Dorn PL, Klotz JH, et al. Feeding behavior of triatomines from the southwestern United States: an update on potential risk for transmission of Chagas disease. Acta Trop 2009, 111(2):114.
22. Coronado X, Rozas M, Botto-Mahan C, et al. Molecular epidemiology of Chagas disease in the wild transmission cycle: the evaluation in the sylvatic vector Mepraia spinolai from an endemic area of Chile. Am J Trop Med Hyg 2009, 81(4):656.
23. Lisboa CV, Mangia RH, Rubiao E, et al. Trypanosoma cruzi transmission in a captive primate unit, Rio de Janeiro, Brazil. Acta Trop 2004, 90(1):97.
24. Williams JT, Dick EJ, Vandeberg JL, et al. Natural Chagas disease in four baboons. J Med Primatol 2009, 38:107.
25. Gurtler RE, Cecere MC, Petersen RM, et al. Chagas disease in north-west Argentina: association between Trypanosoma cruzi parasitaemia in dogs and cats and infection rates in domestic Triatoma infestans. Trans R Soc Trop Med Hyg 1993, 87:12.
26. Cohen JE, Gurtler RE Modeling household transmission of American trypanosomiasis. Science 2001, 293(5530):694.
27. Cecere MC, Gurtler RE, Canale DM, et al. Effects of partial housing improvement and insecticide spraying on the reinfestation dynamics of Triatoma infestans in rural northwestern Argentina. Acta Tropica 2002, 84(2):101.
28. Sabino EC, Goncalez TT, Salles NA, et al. Trends in the prevalence of Chagas disease among first-time blood donors in São Paulo, Brazil. Transfusion 2003, 43(7):853.
29. Laranja FS, Dias E, Nobrega G, et al. Chagas disease: a clinical, epidemiologic, and pathologic study. Circulation 1956, 14:1035.
30. Ramos-Ligonio A, López-Monteon A, Guzmán-Gómez D, et al. Identification of a hyperendemic area for Trypanosoma cruzi infection in central Veracruz, Mexico. Am J Trop Med Hyg 2010, 83(1):164.
31. Galaviz-Silva L, Molina-Garza DP, Gonzalez-Santos MA, et al. Update on seroprevalence of anti- Trypanosoma cruzi antibodies among blood donors in northeast Mexico. Am J Trop Med Hyg 2009, 81(3):404.
32. Salvatella R Current Status of Chagas Disease 2006, Pan American Health Association, Washington, DC.
33. Schmunis GA American trypanosomiasis and its impact on public health in the Americas [Portuguese]. Trypanosoma cruzi e Doença de Chagas 2000, 1. Guanabara Koogan, Rio de Janeiro. 2nd ed. Z. Brener, Z.A. Andrade, M. Barral-Netto (Eds.).
34. Segura EL, Cura EN, Estani SA, et al. Long-term effects of a nationwide control program on the seropositivity for Trypanosoma cruzi infection in young men from Argentina. Am J Trop Med Hyg 2000, 62(3):353.
35. Rassi A, Luquetti AO, Ornelas JF, et al. [The impact of the extensive chemical control of Triatoma infestans on the incidence of acute cases and the prevalence of human Chagas disease. The example of Montalvania, Minas Gerais State [Portuguese]. Rev Soc Bras Med Trop 2003, 36(6):719.
36. Schofield CJ, Jannin J, Salvatella R The future of Chagas disease control. Trends Parasitol 2006, 22:583.
37. Dias JC Southern Cone Initiative for the elimination of domestic populations of Triatoma infestans and the interruption of transfusional Chagas disease. Historical aspects, present situation, and perspectives. Mem Inst Oswaldo Cruz 2007, 102(suppl 1):11.
38. Moncayo A, Silveira AC Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz 2009, 104(suppl 1):17.
39. Salvatella R Andean subregional Chagas disease area and the Andean initiative of Chagas disease. Mem Inst Oswaldo Cruz 2007, 102(suppl 1):39.
40. Anonymous Chagas disease: Central American initiative launched. TDR News 1998, (55):6.
41. Guzman-Bracho C Epidemiology of Chagas disease in Mexico: an update. Trends Parasitol 2001, 17(8):372.
42. Secretaría de Salud. Norma Oficial Mexicana NOM-032-SSA2-202, para la Vigilancia Epidemiológica, Prevención y Control de Enfermedades Transmitidas por Vector Available online at, 2002. Estados Unidos Mexicanos. http://www.mex.ops-oms.org/documentos/chagas/NOM%20032%20SSA2%202002.pdf .
43. Coura JR, Junqueira AC, Boia MN, et al. Chagas disease in the Brazilian Amazon: IV. a new cross-sectional study. Rev Inst Med Trop Sao Paulo 2002, 44(3):159.
44. Dias JP, Bastos C, Araujo E, et al. Acute Chagas disease outbreak associated with oral transmission. Rev Soc Bras Med Trop 2008, 41(3):296.
45. Beltrao HB, Cerroni MP, Freitas DR, et al. Investigation of two outbreaks of suspected oral transmission of acute Chagas disease in the Amazon region, Para State, Brazil, in 2007. Trop Doct 2009, 39(4):231.
46. Bastos CJ, Aras R, Mota G, et al. Clinical outcomes of thirteen Chagas disease patients acquired through oral transmission from two urban outbreaks in northeastern Brazil. PLoS Negl Trop Dis 2010, 4(6):e711.
47. Pereira KS, Schmidt FL, Guaraldo AM, et al. Chagas disease as a foodborne illness. J Food Prot 2009, 72(2):441.
48. Pinto AY, Ferreira AG, Valente VC, et al. Urban outbreak of acute Chagas disease in Amazon region of Brazil: four-year follow-up after treatment with benznidazole. Rev Panam Salud Publica 2009, 25(1):77.
49. Araujo CA, Waniek PJ, Jansen AM An overview of Chagas disease and the role of triatomines on its distribution in Brazil. Vector-Borne Zoonotic Dis 2009, 9(3):227.
50. Sosa-Estani S, Cura E, Velazquez E, et al. Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission. Rev Soc Bras Med Trop 2009, 42(5):484.
51. Bern C, Verastegui M, Gilman RH, et al. Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin Infect Dis 2009, 49(11):1667.
52. Amorim DdS Chagas disease. Prog Cardiol 1979, 8:235.
53. Falla A, Herrera C, Fajardo A, et al. Haplotype identification within Trypanosoma cruzi I in Colombian isolates from several reservoirs, vectors and humans. Acta Trop 2009, 110(1):15.
54. del Puerto R, Nishizawa JE, Kikuchi M, et al. Lineage analysis of circulating Trypanosoma cruzi parasites and their association with clinical forms of Chagas disease in Bolivia. PLoS Negl Trop Dis 2010, 4(5):e687.
55. Ochs DE, Hnilica V, Moser DR, et al. Postmortem diagnosis of autochthonous acute chagasic myocarditis by polymerase chain reaction amplification of a species-specific DNA sequence of Trypanosoma cruzi. Am J Trop Med Hyg 1996, 34:526.
56. Herwaldt BL, Grijalva MJ, Newsome AL, et al. Use of polymerase chain reaction to diagnose the fifth reported US case of autochthonous transmission of Trypanosoma cruzi, in Tennessee, 1998. J Infect Dis 2000, 181(1):395.
57. Dorn PL, Perniciaro L, Yabsley MJ, et al. Autochthonous transmission of Trypanosoma cruzi, Louisiana. Emerg Infect Dis 2007, 13(4):605.
58. Crovato F, Rebora A Chagas disease: a potential problem for Europe?. Dermatology 1997, 195:184.
59. Lescure FX, Canestri A, Melliez H, et al. Chagas disease, France. Emerg Infect Dis 2008, 14(4):644.
60. U.S.Census Bureau Foreign-Born Population by Place of Birth and Citizenship Status: 2006. Statistical Abstract of the United States: 2008 2008, US Department of Commerce, Washington, DC.
61. Centers for Disease Control and Prevention Blood donor screening for Chagas disease - United States, 2006-2007. MMWR 2007, 56(07):141.
62. Bern C, Montgomery SP An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009, 49(5):e52.
63. Dodd R Managing the microbiological safety of blood for transfusion: a US perspective. Future Microbiol 2009, 4:807.
64. Leiby DA, Lenes BA, Tibbals MA, et al. Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med 1999, 341(16):1237.
65. Young C, Losikoff P, Chawla A, et al. Transfusion-acquired Trypanosoma cruzi infection. Transfusion 2007, 47:540.
66. El Ghouzzi MH, Boiret E, Wind F, et al. Testing blood donors for Chagas disease in the Paris area, France: first results after 18 months of screening. Transfusion 2010, 50(3):575.
67. Lucas RM, Barba MC [Prevalence of american tripanosomiasis in pregnant women from a health area of Valencia, Spain: 2005-2007.]. Rev Esp Salud Publica 2009, 83(4):543.
68. Centers for Disease Control and Prevention Chagas disease after organ transplantation - United States, 2001. MMWR 2002, 51(10):210.
69. Centers for Disease Control and Prevention Chagas disease after organ transplantation - Los Angeles, California, 2006. MMWR 2006, 55(29):798.
70. Rassi A, Rassi Junior A, Rassi GG Acute Chagas disease. [Portuguese]. Trypanosoma cruzi e Doença de Chagas 2000, 231. Guanabara Koogan, Rio de Janeiro. Z. Brener, Z.A. Andrade, M. Barral-Netto (Eds.).
71. Parada H, Carrasco HA, Anez N, et al. Cardiac involvement is a constant finding in acute Chagas disease: a clinical, parasitological and histopathological study. Int J Cardiol 1997, 60(1):49.
72. Hoff R, Teixeira RS, Carvalho JS, et al. Trypanosoma cruzi in the cerebrospinal fluid during the acute stage of Chagas disease. N Engl J Med 1978, 298:604.
73. Kirchhoff LV Trypanosomiasis of the central nervous system. Infections of the Central Nervous System 2004, 777. Lippincott Williams & Wilkins, Philadelphia. 3rd ed. W.M. Scheld, C.M. Marra, R.J. Whitely (Eds.).
74. Kirchhoff LV, Weiss LM, Wittner M, et al. Parasitic diseases of the heart. Front Biosci 2004, 9:706.
75. Rassi A, Rassi A, Little WC, et al. Development and validation of a risk score for predicting death in Chagas heart disease. N Engl J Med 2006, 355(8):799.
76. Isselbacher EM, Kligerman SJ, Lam KM, Hurtado RM Case records of the Massachusetts General Hospital. Case 2-2010. A 47-year-old man with abdominal and flank pain. N Engl J Med 2010, 362(3):254.
77. Tanowitz HB, Machado FS, Jelicks LA, et al. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis 2009, 51(6):524.
78. Marin-Neto JA, Rassi JA Update on Chagas heart disease on the first centenary of its discovery. Rev Esp Cardiol 2009, 62(11):1211.
79. Rassi A, Rassi A, Marin-Neto JA Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Mem Inst Oswaldo Cruz 2009, 104(suppl 1):152.
80. Andrade ZA, Andrade SG Patologia. Trypanosoma cruzi e Doença de Chagas 1979, 199. Guanabara Koogan, Rio de Janeiro. Z. Brener, Z.A. Andrade (Eds.).
81. Andrade ZA Patologia da doença de Chagas [Portuguese]. Trypanosoma cruzi e Doença de Chagas 2000, 201. Guanabara Koogan, Rio de Janeiro. 2nd ed. Z. Brener, Z.A. Andrade, M. Barral-Netto (Eds.).
82. Marin-Neto JA, Cunha-Neto E, Maciel BC, et al. Pathogenesis of chronic Chagas heart disease. Circulation 2007, 115:1109.
83. Jones EM, Colley DG, Tostes S, et al. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg 1993, 48:348.
84. Zhang L, Tarleton RL Parasite persistence correlates with disease severity and localization in chronic Chagas disease. J Infect Dis 1999, 180(2):480.
85. Benvenuti LA, Roggerio A, Freitas HF, et al. Chronic American trypanosomiasis: parasite persistence in endomyocardial biopsies is associated with high-grade myocarditis. Ann Trop Med Parasitol 2008, 102(6):481.
86. Kirchhoff LV, Neva FA Chagas disease in Latin American immigrants. JAMA 1985, 254:3058.
87. Oliveira-Filho J, Viana LC, Vieira-de-Melo RM, et al. Chagas disease is an independent risk factor for stroke: baseline characteristics of a Chagas disease cohort. Stroke 2005, 36(9):2015.
88. Trabuco CC, Pereira de Jesus PA, Bacellar AS, et al. Successful thrombolysis in cardioembolic stroke from Chagas disease. Neurology 2005, 64(1):170.
89. Kirchhoff LV American trypanosomiasis (Chagas disease). Gastroenterol Clini N Am 1996, 25(3):517.
90. de Oliveira RB, Troncon LE, Dantas RO, et al. Gastrointestinal manifestations of Chagas disease. Am J Gastroenterol 1998, 93(6):884.
91. Koberle F Chagas disease and Chagas syndromes: the pathology of American trypanosomiasis. Adv Parasitol 1968, 6:63.
92. Rezende JM, Moreira H Forma digestiva da doença de Chagas [Portuguese]. Trypanosoma cruzi e Doença de Chagas 2000, 297. Guanabara Koogan, Rio de Janeiro. 2nd ed. Z. Brener, Z.A. Andrade, M. Barral-Netto (Eds.).
93. Troncon LEA, Oliveira RB, Romanello LMF, et al. Abnormal progression of a liquid meal through the stomach and small intestine in patients with Chagas disease. Dig Dis Sci 1993, 38(8):1511.
94. Bonney KM, Engman DM Chagas heart disease pathogenesis: one mechanism or many?. Curr Mol Med 2008, 8(6):510.
95. Gutierrez FR, Guedes PM, Gazzinelli RT, et al. The role of parasite persistence in pathogenesis of Chagas heart disease. Parasite Immunol 2009, 31(11):673.
96. Riarte A, Luna C, Sabatiello R, et al. Chagas disease in patients with kidney transplants: 7 years of experience 1989-1996. Clin Infect Dis 1999, 29(3):561.
97. Gallerano V, Consigli J, Pereyra S, et al. Chagas disease reactivation with skin symptoms in a patient with kidney transplant. Int J Dermatol 2007, 46(6):607.
98. Marchiori PE, Alexandre PL, Britto N, et al. Late reactivation of Chagas disease presenting in a recipient as an expansive mass lesion in the brain after heart transplantation of chagasic myocardiopathy. J Heart Lung Transplant 2007, 26(11):1091.
99. Campos SV, Strabelli TM, Amato NV, et al. Risk factors for Chagas disease reactivation after heart transplantation. J Heart Lung Transplant 2008, 27(6):597.
100. Gluckstein D, Ciferri F, Ruskin J Chagas disease: another cause of cerebral mass in the acquired immunodeficiency syndrome. Am J Med 1992, 92:429.
101. Lambert N, Mehta B, Walters R, et al. Chagasic encephalitis as the initial manifestation of AIDS. Ann Intern Med 2006, 144:941.
102. Sartori AM, Sotto MN, Braz LM, et al. Reactivation of Chagas disease manifested by skin lesions in a patient with AIDS. Trans R Soc Trop Med Hyg 1999, 93(6):631.
103. Sartori AM, Ibrahim KY, Braz A, et al. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol 2007, 101(1):31.
104. Moretta G, Pettinicchi JP, Talarico ME, et al. Clinical reasoning: a 35-year-old man with a right hemiplegia and a cerebral mass. Neurology 2009, 73(8):e35.
105. Luquetti AO, Rassi A Laboratory diagnosis of Trypanosoma cruzi infection [Portuguese]. Trypanosoma cruzi e Doença de Chagas Guanabara Koogan 2000, 344. Guanabara Koogan, Rio de Janeiro. 2nd ed. Z. Brener, Z. Andrade, M. Barral-Netto (Eds.).
106. Chiari E, Dias JCP, Lana M, et al. Hemocultures for the parasitological diagnosis of human chronic Chagas disease. Rev Soc Bras Med Trop 1989, 22:19.
107. Gomes ML, Galvao LMC, Macedo AM, et al. Chagas disease diagnosis: comparative analysis of parasitologic, molecular, and serologic methods. Am J Trop Med Hyg 1999, 60(2):205.
108. Castro AM, Luquetti AO, Rassi A, et al. Blood culture and polymerase chain reaction for the diagnosis of the chronic phase of human infection with Trypanosoma cruzi. Parasitol Res 2002, 88(10):894.
109. Freilij H, Altcheh J Congenital Chagas disease: diagnostic and clinical aspects. Clin Infect Dis 1995, 21(3):551.
110. Leiby DA, Wendel S, Takaoka DT, et al. Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits. J Clin Microbiol 2000, 38(2):639.
111. Gorlin J, Rossmann S, Robertson G, et al. Evaluation of a new Trypanosoma cruzi antibody assay for blood donor screening. Transfusion 2008, 48(3):531.
112. Caballero ZC, Sousa OE, Marques WP, et al. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp. Clin Vaccine Immunol 2007, 14(8):1045.
113. Luquetti AO, Espinoza B, Martinez I, et al. Performance levels of four Latin American laboratories for the serodiagnosis of Chagas disease in Mexican sera samples. Mem Inst Oswaldo Cruz 2009, 104(5):797.
114. Remesar MC, Gamba C, Colaianni IF, et al. Estimation of sensitivity and specificity of several Trypanosoma cruzi antibody assays in blood donors in Argentina. Transfusion 2009, 49(11):2352.
115. Otani MM, Vinelli E, Kirchhoff LV, et al. WHO comparative evaluation of serologic assays for Chagas disease. Transfusion 2009, 49:1076.
116. Oelemann W, Vanderborght BO, Verissimo Da Costa GC, et al. A recombinant peptide antigen line immunoassay optimized for the confirmation of Chagas disease. Transfusion 1999, 39(7):711.
117. Chang CD, Cheng KY, Jiang L, et al. Evaluation of a prototype Trypanosoma cruzi antibody assay with recombinant antigens on a fully automated chemiluminescence analyzer for blood donor screening. Transfusion 2006, 46(10):1737.
118. Cheng KY, Chang CD, Salbilla VA, et al. Immunoblot assay using recombinant antigens as a supplemental test to confirm antibodies to Trypanosoma cruzi. Clini Vaccine Immunol 2007, 14(4):355.
119. Houghton RL, Stevens YY, Hjerrild K, et al. A lateral flow immunoassay for diagnosis of Trypanosoma cruzi infection with high correlation to radioimmunoprecipitation assay. Clin Vaccine Immunol 2009, 16:515.
120. Ramirez JD, Guhl F, Umezawa ES, et al. Evaluation of adult chronic Chagas heart disease diagnosis by molecular and serological methods. J Clin Microbiol 2009, 47:3945.
121. Trypanosoma cruzi (T. cruzi), Whole Cell Lysate Antigen, ORTHO® T. cruzi ELISA Test System (package insert) 2006, Ortho-Clinical Diagnostics, Inc, Raritan, NJ.
122. Kirchhoff LV, Gam AA, Gusmao RD, et al. Increased specificity of serodiagnosis of Chagas disease by detection of antibody to the 72- and 90-kilodalton glycoproteins of Trypanosoma cruzi. J Infect Dis 1987, 155:561.
123. Moser DR, Kirchhoff LV, Donelson JE Detection of Trypanosoma cruzi by polymerase chain reaction gene amplification. J Clin Microbiol 1989, 27:1744.
124. Kirchhoff LV, Votava JR, Ochs DE, et al. Comparison of PCR and microscopic methods for detecting Trypanosoma cruzi. J Clin Microbiol 1996, 34(5):1171.
125. Sturm NR, Degrave W, Morel C, et al. Sensitive detection and schizodeme classification of Trypanosoma cruzi cells by amplification of kinetoplast minicircle DNA sequences: use in diagnosis of Chagas disease. Mol Biochem Parasitol 1989, 33:205.
126. Virreira M, Torrico F, Truyens C, et al. Comparison of polymerase chain reaction methods for reliable and easy detection of congenital Trypanosoma cruzi infection. Am J Trop Med Hyg 2003, 68(5):574.
127. Russomando G, de Tomassone MM, de Guillen I, et al. Treatment of congenital Chagas disease diagnosed and followed up by the polymerase chain reaction. Am J Trop Med Hyg 1998, 59(3):487.
128. Britto CC Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations. Mem Inst Oswaldo Cruz 2009, 104(suppl 1):122.
129. Urbina JA Chemotherapy of Chagas disease. Curr Pharm Des 2002, 8(4):287.
130. Coura JR, de Castro SL A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 2002, 97(1):3.
131. Kirchhoff LV Nifurtimox. Antimicrobial Therapy and Vaccines 2004, 867. Apple Trees Productions, New York. V. Yu, R. Weber, D. Raoult (Eds.).
132. Altcheh J, Biancardi M, Lapena A, et al. [Congenital Chagas disease: experience in the Hospital de Niños, Ricardo Gutierrez, Buenos Aires, Argentina.]. Rev Soc Bras Med Trop 2005, 45(suppl 2):41.
133. Kirchhoff LV Benznidazole. Antimicrobial Therapy and Vaccines 2004, 762. Apple Trees Productions, New York. V. Yu, R. Weber, D. Raoult (Eds.).
134. Sosa-Estani S, Segura EL, Ruiz AM, et al. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas disease. Am J Trop Med Hyg 1998, 59(4):526.
135. Streiger ML, del Barco ML, Babbro DL, et al. Longitudinal study and specific chemotherapy in children with chronic Chagas disease, residing in a low endemicity area of Argentina [Portuguese]. Rev Soc Bras Med Trop 2004, 37(5):365.
136. Andrade AL, Martelli CM, Oliveira RM, et al. Short report: benznidazole efficacy among Trypanosoma cruzi-infected adolescents after a six-year follow-up. Am J Trop Med Hyg 2004, 71(5):594.
137. Sosa-Estani S, Segura EL Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina. Curr Opin Infect Dis 2006, 19:583.
138. Braga MS, Lauria-Pires L, Arganaraz ER, et al. Persistent infections in chronic Chagas disease patients treated with anti- Trypanosoma cruzi nitroderivatives. Rev Inst Med Trop Sao Paulo 2000, 42(3):157.
139. Lauria-Pires L, Braga MS, Vexenat AC, et al. Progressive chronic Chagas heart disease ten years after treatment with anti- Trypanosoma cruzi nitroderivatives. Am J Trop Med Hyg 2000, 63(3-4):111.
140. Lauria-Pires L, Nitz N, Vexenat AC, et al. The treatment of Chagas disease patients with nitroderivative is unsatisfactory. Rev Inst Med Trop Sao Paulo 2001, 43(3):175.
141. Cancado JR Long term evaluation of etiological treatment of Chagas disease with benznidazole. Rev Inst Med Trop Sao Paulo 2002, 44(1):29.
142. Villar JC, Marin-Neto JA, Ebrahim S, et al. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection. Cochrane Database Syst Rev 2002, 1:CD003463.
143. Perez-Molina JA, Perez-Ayala A, Moreno S, et al. Use of benznidazole to treat chronic Chagas disease: a systematic review with a meta-analysis. J Antimicrob Chemother 2009, 64(6):1139.
144. Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 2007, 298(18):2171.
145. Marin-Neto JA, Rassi A, Morillo CA, et al. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J 2008, 156(1):37.
146. Marin-Neto JA, Rassi A, Avezum A, et al. The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Mem Inst Oswaldo Cruz 2009, 104(suppl 1):319.
147. Soeiro MN, Dantas AP, Daliry A, et al. Experimental chemotherapy for Chagas disease: 15 years of research contributions from in vivo and in vitro studies. Mem Inst Oswaldo Cruz 2009, 104(suppl 1):301.
148. McKerrow JH, Doyle PS, Engel JC, et al. Two approaches to discovering and developing new drugs for Chagas disease. Mem Inst Oswaldo Cruz 2009, 104(suppl 1):263.
149. Urbina JA Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop 2010, 115:55.
150. Teixeira ARL, Silva R, Cunha Neto E, et al. Malignant, non-Hodgkin's lymphomas in Trypanosoma cruzi-infected rabbits treated with nitroarenes. J Comp Pathol 1990, 103:37.
151. Teixeira ARL, Cordova JC, Souto Maior I, et al. Chagas disease: Lymphoma growth in rabbits treated with benznidazole. Am J Trop Med Hyg 1990, 43:146.
152. Pazin-Filho A, Romano MM, Gomes FR, et al. Left ventricular global performance and diastolic function in indeterminate and cardiac forms of Chagas disease. J Am Soc Echocardiogr 2007, 20(12):1338.
153. Rocha MO, Teixeira MM, Ribeiro AL An update on the management of Chagas cardiomyopathy. Expert Rev Anti Infect Ther 2007, 5(4):727.
154. Rocha MO, Nunes MC, Ribeiro AL Morbidity and prognostic factors in chronic chagasic cardiopathy. Mem Inst Oswaldo Cruz 2009, 104(suppl 1):159.
155. Rassi A, Rassi A, Rassi SG Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation 2007, 115:1101.
156. Rincon LG, Rocha MO, Pires MT, et al. [Clinical profile of Chagas and non-Chagas disease patients with cardiac pacemaker.]. Rev Soc Bras Med Trop 2006, 39(3):245.
157. Soares MB, Dos Santos RR Current status and perspectives of cell therapy in Chagas disease. Mem Inst Oswaldo Cruz 2009, 104(suppl 1):325.
158. Kirchhoff LV American trypanosomiasis (Chagas disease) - a tropical disease now in the United States. N Engl J Med 1993, 329:639.
159. Bacal F, Silva CP, Pires PV, et al. Transplantation for Chagas disease: an overview of immunosuppression and reactivation in the last two decades. Clin Transplant 2010, 24(2):E29.
160. Godoy HL, Guerra CM, Viegas RF, et al. Infections in heart transplant recipients in Brazil: the challenge of Chagas disease. J Heart Lung Transplant 2010, 29(3):286.
161. Diez M, Favaloro L, Bertolotti A, et al. Usefulness of PCR strategies for early diagnosis of Chagas disease reactivation and treatment follow-up in heart transplantation. Am J Transplant 2007, 7(6):1633.
162. Campos SV, Strabelli TM, Amato NV, et al. Risk factors for Chagas disease reactivation after heart transplantation. J Heart Lung Transplant 2008, 27(6):597.
163. Palma JH, Guilhen JC, Gaia DF, et al. Post-transplant lymphoproliferative disease presenting as a mass in the left ventricle in a heart transplant recipient at long-term follow-up. J Heart Lung Transplant 2009, 28(2):206.
164. Libow LF, Beltrani VP, Silvers DN, et al. Post-cardiac transplant reactivation of Chagas disease diagnosed by skin biopsy. Cutis 1991, 48:37.
165. Bocchi EA, Fiorelli A The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology. Ann Thor Surg 2001, 71(6):1833.
166. Herbella FA, Oliveira DR, Del Grande JC Are idiopathic and Chagasic achalasia two different diseases?. Dig Dis Sci 2004, 49(3):353.
167. Herbella FA, Aquino JL, Stefani-Nakano S, et al. Treatment of achalasia: lessons learned with Chagas disease. Dis Esophagus 2008, 21(5):461.
168. Pinotti HW, Habr-Gama A, Cecconello I, et al. The surgical treatment of megaesophagus and megacolon. Dig Dis 1993, 11:206.
169. Pinotti HW, Felix VN, Zilberstein B, et al. Surgical complications of Chagas disease: megaesophagus, achalasia of the pylorus, and cholelithiasis. World J Surg 1991, 15:198.
170. Brant C, Moraes-Filho JP, Siqueira E, et al. Intrasphincteric botulinum toxin injection in the treatment of chagasic achalasia. Dis Esophagus 2003, 16(1):33.
171. Kobayasi S, Mendes EF, Rodrigues MAM, et al. Toxic dilatation of the colon in Chagas disease. Br J Surg 1992, 79:1202.
172. Garcia RL, de Matos BM, Feres O, et al. Surgical treatment of Chagas megacolon. Critical analysis of outcome in operative methods. Acta Cir Bras 2008, 23(suppl 1):83.
173. Nahas SC, Pinto RA, Dias AR, et al. Long-term follow-up of abdominal rectosigmoidectomy with posterior end-to-side stapled anastomosis for Chagas megacolon. Colorectal Dis 2009, (in press).
174. Coura JR, Dias JC Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery. Mem Inst Oswaldo Cruz 2009, 104(suppl 1):31.
175. Dias JC Elimination of Chagas disease transmission: perspectives. Mem Inst Oswaldo Cruz 2009, 104(suppl 1):41.
176. Hudson L, Grover F, Gutteridge WE, et al. Suggested guidelines for work with live Trypanosoma cruzi. Trans R Soc Trop Med Hyg 1983, 77:416.
177. Biosafety in Microbiological and Biomedical Laboratories (BMBL). U.S. Department of Health and Human Services. 5th ed. Washington, DC: U.S. Government Printing Office; 2009.